Dr. Sunil Rangappa, MD

Dr. Rangappa practices at Socal Heart Care in Granada Hills, California.

Dr. Rangappa's NPI, 1730392887, was assigned on May 7, 2007. Dr. Rangappa graduated from Bangalore Medical College in 2001. Dr. Rangappa's California license number on file is A93249.

Dr. Rangappa's primary practice is Socal Heart Care, at 10515 N Balboa Blvd, Granada Hills, CA 91344 in Los Angeles County. The practice phone is (818) 305-5671.

Dr. Rangappa's primary practice is Socal Heart Care in Granada Hills, California. Dr. Rangappa is also affiliated with Dignity Health - Northridge Hospital Medical Center. Dmand AI also links Dr. Rangappa to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rangappa practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rangappa's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Rangappa's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension, coronary artery disease and heart failure among the conditions Dr. Rangappa treats.

CMS data shows 6,826 Medicare services from Dr. Rangappa across 15 procedure codes in 2024, for 1,095 Medicare patients. Medicare paid $623,761 for them.

CMS counts 1,095 Medicare patients who saw Dr. Rangappa in 2024. The largest group is 65 to 74, with 374 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 85% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rangappa's median patient age at 64, with 48% women.

In 2024, Dr. Rangappa wrote 2,616 Medicare Part D claims for 271 patients. 83% of them were for generic drugs. CMS names the drug for 2,454 of them, across 31 drugs with 11 or more claims each, at $296,866 in total drug cost. In 2023, CMS named 1,999 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rangappa for performance year 2024, reported individually. Dr. Rangappa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Rangappa. The most frequent topics are Stem Cells, Cell Differentiation and Mesoderm. Dr. Rangappa's most frequent co-author is James Summers Forrester, MD.

Dmand AI links Dr. Rangappa to 1 clinical trial. Conditions studied include Obesity and Overnutrition. Open Payments lists research payments to Dr. Rangappa that name 1 trial.

CMS Open Payments shows 200 general payments to Dr. Rangappa from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $1,968. It also lists 1 research payment totaling $1,208 in 2021, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Rangappa, most recently CMS Stage 1 2012 in 2011.

Dr. Rangappa graduated from Bangalore Medical College in 2001. Dr. Rangappa is a member of ACC, AHA, ASNC and National Board of Echocardiography.

Dr. Rangappa is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.